Trial Profile
A Study to Evaluate the Efficacy and Tolerance of Sofosbuvir-based Therapy in Patients with Chronic Hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2015 New trial record